Ocular Drug Delivery Solutions

  1. Formulation Strategies For Poorly Soluble Molecules 10/15/2025

    As the number of poorly soluble compounds continues to increase in the industry development pipeline, conventional formulation strategies may not be sufficient to achieve acceptable levels of solubility in the gastrointestinal tract and hence absorption into the systemic circulation.

  2. Simplify The Journey With A Combination Product Solution 10/27/2025

    Developing combination products requires navigating complex regulations. A solution that combines packaging, delivery systems, and expert support can accelerate your path to market and reduce risk.

  3. A/L/P Assembly, Label And Packaging 11/7/2025

    Integrated device assembly, labeling, and packaging solutions streamline pharma delivery, ensuring compliance, scalability, and patient-centric design from clinical trials to commercial production.

  4. Pharma Services Fill, Finish & Drug Delivery CDMO 11/7/2025

    Sterile fill-finish and device assembly capabilities span global sites, offering scalable solutions, analytical testing, and regulatory compliance for combination products and small-batch technical programs.

  5. Protein Degraders: From Discovery To Development 11/18/2025

    Leverage integrated platforms for targeted protein degradation and molecular glue solutions, from ligand identification to IND-enabling studies. Advanced screening and structural biology support accelerate discovery.

  6. NanoImprove The Performance Of Your Biologic Formulation 11/20/2025

    Unlock superior performance for peptides and proteins using nanotechnology. Achieve high drug loads for subcutaneous delivery and stable, aerodynamic dry powders for deep-lung inhalation.

  7. Innovative Formulations And Higher Drug Loads Across The Life-Cycle 11/20/2025

    Advanced particle engineering enhances the performance and life-cycle of therapeutics. Superior bioavailability, higher drug load, and improved stability are enabled for small and large molecules.

  8. Multiparticulates For Modified Release Systems 1/12/2026

    Multiparticulates enable tailored drug release with improved flexibility, dose accuracy, and patient convenience, leveraging technologies like Diffucaps® for customized profiles including immediate, delayed, extended, and pulsatile delivery.

  9. A Leading Drug Delivery CDMO 2/2/2026

    A look at integrated drug‑delivery expertise, scalable development paths, and advanced manufacturing that speed programs from formulation to global launch while reducing risk and improving efficiency.

  10. Bridgeton – Our World Class Fill Finish Facility 2/2/2026

    A scalable aseptic environment for diverse injectables, advanced automation, and Annex 1–aligned processes, supporting smooth transitions from development to commercial supply and long‑term strategy.